D. Serin
Impact in
- Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Bone health and treatments
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
-
- Breast Cancer Treatment Studies 19
- Oncology 27
- Cancer Treatment and Pharmacology 15
- Cancer survivorship and care 6
- Global Cancer Incidence and Screening 5
- HER2/EGFR in Cancer Research 4
- Co-authors
- P. Fumoleau (4 shared papers)M. Namer (10 shared papers)R. Largillier (2 shared papers)Jacques M Bonneterre (2 shared papers)Eric Vuillemin (2 shared papers)Jean‐François Morère (3 shared papers)Bruno Audhuy (2 shared papers)Thierry Lesimple (1 shared paper)
- Journals
- European Journal of Cancer (9 papers)Annals of Oncology (4 papers)Cancer Research (2 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- FranceBelgiumUnited Kingdom
In The Last Decade
D. Serin
55 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Oncology 622
- Cancer Research 304
- Genetics 369
- Dermatology 104
- Public Health, Environmental and Occupational Health 185
Countries citing papers authored by D. Serin
This map shows the geographic impact of D. Serin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Serin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Serin more than expected).
Fields of papers citing papers by D. Serin
This network shows the impact of papers produced by D. Serin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Serin. The network helps show where D. Serin may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Serin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 258 | |
| 2 | 2009 | 137 | |
| 3 | 1997 | 127 | |
| 4 | 1996 | 112 | |
| 5 | 2003 | 95 | |
| 6 | 2006 | 53 | |
| 7 | Phase II randomized study of paclitaxel versus mitomycin in advanced breast cancer. | 1995 | 42 |
| 8 | 1999 | 42 | |
| 9 | 2006 | 37 | |
| 10 | 1996 | 34 | |
| 11 | [Frequency of lymphedema of the upper limb after treatment of breast cancer. Risk factors. Apropos of 683 cases]. | 1996 | 26 |
| 12 | 2007 | 26 | |
| 13 | [Lymphoscintigraphic aspects of the effects of manual lymphatic drainage]. | 1996 | 25 |
| 14 | 2001 | 22 | |
| 15 | 1993 | 17 | |
| 16 | 2008 | 17 | |
| 17 | 2004 | 14 | |
| 18 | 2012 | 14 | |
| 19 | 2002 | 13 | |
| 20 | 1982 | 12 |
About D. Serin
D. Serin is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Dermatology, having authored 57 papers that have together received 1.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), Cancer Treatment and Pharmacology (15 papers), Estrogen and related hormone effects (6 papers), Cancer survivorship and care (6 papers), Global Cancer Incidence and Screening (5 papers), Chemotherapy-related skin toxicity (5 papers), BRCA gene mutations in cancer (5 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (622 citations), Cancer Research (304 citations), Genetics (369 citations), Dermatology (104 citations) and Public Health, Environmental and Occupational Health (185 citations). D. Serin has collaborated with scholars based in France, Belgium and United Kingdom. Frequent co-authors include P. Fumoleau, M. Namer, R. Largillier, Jacques M Bonneterre, Eric Vuillemin, Jean‐François Morère, Bruno Audhuy, Thierry Lesimple, Hector W. Cure and François Montestruc. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Cancer Research, International Journal of Radiation Oncology*Biology*Physics and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.